Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region's genetic variability.

Prezioso C, Ciotti M, Obregon F, Ambroselli D, Rodio DM, Cudillo L, Gaziev J, Mele A, Nardi A, Favalli C, Arcese W, Palamara AT, Pietropaolo V.

Med Microbiol Immunol. 2019 Dec;208(6):845-854. doi: 10.1007/s00430-019-00630-9. Epub 2019 Aug 2.

2.

Performance Evaluation of a New Culture Colorimetric Detection Assay.

Favalli C, Favaro M, Santi F, Piperno M, D'Agostini C, Ciotti M.

Eurasian J Med. 2019 Feb;51(1):5-7. doi: 10.5152/eurasianjmed.2018.17364. Epub 2018 Nov 30.

3.

Comparison of coronal leakage of different root canal filling techniques: an ex vivo study.

Libonati A, Di Taranto V, D Agostini C, Santoro MM, Di Carlo D, Ombres D, Gallusi G, Favalli C, Marzo G, Campanella V.

J Biol Regul Homeost Agents. 2018 Mar-Apr;32(2):397-405.

PMID:
29685025
4.

Rapid and cost-effective identification and antimicrobial susceptibility testing in patients with Gram-negative bacteremia directly from blood-culture fluid.

Sakarikou C, Altieri A, Bossa MC, Minelli S, Dolfa C, Piperno M, Favalli C.

J Microbiol Methods. 2018 Mar;146:7-12. doi: 10.1016/j.mimet.2018.01.012. Epub 2018 Feb 3.

PMID:
29366760
5.
6.

Detection of HPV and co-infecting pathogens in healthy Italian women by multiplex real-time PCR.

Camporiondo MP, Farchi F, Ciccozzi M, Denaro A, Gallone D, Maracchioni F, Favalli C, Ciotti M.

Infez Med. 2016;24(1):12-7.

7.

Historical review on thymosin α1 in oncology: preclinical and clinical experiences.

Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, Camerini R, Palamara AT, Favalli C, Mastino A, Serafino A, Sinibaldi Vallebona P.

Expert Opin Biol Ther. 2015;15 Suppl 1:S31-9. doi: 10.1517/14712598.2015.1017466. Epub 2015 Jun 22. Review.

PMID:
26096345
8.

Tazarotene as alternative topical treatment for onychomycosis.

Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S, Bianchi L, Orlandi A.

Drug Des Devel Ther. 2015 Feb 16;9:879-86. doi: 10.2147/DDDT.S69946. eCollection 2015.

9.

Evaluation of BiesseBioscreen as a new methodology for bacteriuria screening.

Nicolai E, Garau S, Favalli C, D'Agostini C, Gratton E, Motolese G, Rosato N.

New Microbiol. 2014 Oct;37(4):495-501. Epub 2014 Oct 1.

10.

Microbiological Infections in Women With Cervical Cytological Reports of Atypical Squamous Cells of Undetermined Significance.

Paba P, Criscuolo AA, Grazia Giancipoli R, Santi F, Ascone C, Sesti F, Piccione E, Perno CF, Favalli C, Ciotti M.

J Low Genit Tract Dis. 2015 Jul;19(3):203-6. doi: 10.1097/LGT.0000000000000078.

PMID:
25148228
11.

Improved diagnosis of central venous catheter-related bloodstream infections using the HB&L UROQUATTRO™ system.

Fontana C, Favaro M, Bossa MC, Minelli S, Altieri A, Pelliccioni M, Falcione F, Di Traglia L, Cicchetti O, Favalli C.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3139-44. doi: 10.1007/s10096-012-1676-9. Epub 2012 Jun 27.

PMID:
22735899
12.

A multi-target real-time PCR assay for rapid identification of meningitis-associated microorganisms.

Favaro M, Savini V, Favalli C, Fontana C.

Mol Biotechnol. 2013 Jan;53(1):74-9. doi: 10.1007/s12033-012-9534-7.

PMID:
22450734
13.

Emergence of KPC-producing Klebsiella pneumoniae in Italy.

Fontana C, Favaro M, Sarmati L, Natoli S, Altieri A, Bossa MC, Minelli S, Leonardis F, Favalli C.

BMC Res Notes. 2010 Feb 23;3:40. doi: 10.1186/1756-0500-3-40.

14.

Comparison of the eSwab collection and transportation system to an amies gel transystem for Gram stain of clinical specimens.

Fontana C, Favaro M, Limongi D, Pivonkova J, Favalli C.

BMC Res Notes. 2009 Dec 10;2:244. doi: 10.1186/1756-0500-2-244.

15.

A novel culturing system for fluid samples.

Fontana C, Favaro M, Minelli S, Bossa MC, Altieri A, Favalli C.

Med Sci Monit. 2009 Feb;15(2):BR55-60.

PMID:
19179962
16.

Proteomic investigation in A549 lung cell line stably infected by HPV16E6/E7 oncogenes.

Ciotti M, Marzano V, Giuliani L, Nuccetelli M, D'Aguanno S, Azzimonti B, Bernardini S, Perno CF, Urbani A, Favalli C, Federici G.

Respiration. 2009;77(4):427-39. doi: 10.1159/000176209. Epub 2008 Nov 20.

PMID:
19023193
17.

Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways.

Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjänen K, Ciotti M.

Intervirology. 2008;51(4):230-4. doi: 10.1159/000156481. Epub 2008 Sep 24.

PMID:
18812695
18.

Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates.

Fontana C, Favaro M, Minelli S, Bossa MC, Testore GP, Leonardis F, Natoli S, Favalli C.

BMC Infect Dis. 2008 Jun 8;8:79. doi: 10.1186/1471-2334-8-79.

19.

Detection of oncogenic DNA viruses in colorectal cancer.

Giuliani L, Ronci C, Bonifacio D, Di Bonito L, Favalli C, Perno CF, Syrjänen K, Ciotti M.

Anticancer Res. 2008 Mar-Apr;28(2B):1405-10.

20.

Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Int J Gynecol Pathol. 2008 Apr;27(2):265-73. doi: 10.1097/PGP.0b013e318159cbc0.

PMID:
18317213
21.

Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature.

Giuliani L, Favalli C, Syrjanen K, Ciotti M.

Anticancer Res. 2007 Jul-Aug;27(4C):2697-704. Review.

22.

BK virus DNA detection by real-time polymerase chain reaction in clinical specimens.

Marchetti S, Graffeo R, Siddu A, Santangelo R, Ciotti M, Picardi A, Favalli C, Fadda G, Cattani P.

New Microbiol. 2007 Apr;30(2):119-26.

23.

Thymosin alpha 1: from bench to bedside.

Garaci E, Favalli C, Pica F, Sinibaldi Vallebona P, Palamara AT, Matteucci C, Pierimarchi P, Serafino A, Mastino A, Bistoni F, Romani L, Rasi G.

Ann N Y Acad Sci. 2007 Sep;1112:225-34. Epub 2007 Jun 28.

PMID:
17600290
24.

The combined use of VIGI@ct (bioMérieux) and fluorescent amplified length fragment polymorphisms in the investigation of potential outbreaks.

Fontana C, Favaro M, Pistoia ES, Minelli S, Bossa MC, Altieri A, Testore GP, Leonardis F, Natoli S, Favalli C.

J Hosp Infect. 2007 Jul;66(3):262-8. Epub 2007 Jun 1.

PMID:
17544166
25.

Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.

Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D'Antonio D, Syrjanen K, Favalli C, Ciotti M.

Lung Cancer. 2007 Sep;57(3):273-81. Epub 2007 Apr 2.

PMID:
17400331
26.

Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy.

Grelli S, Balestrieri E, Matteucci C, Minutolo A, D'Ettorre G, Lauria F, Montella F, Vullo V, Vella S, Favalli C, Mastino A, Macchi B.

Ann N Y Acad Sci. 2006 Dec;1090:130-7.

PMID:
17384255
27.

Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy.

Balestrieri E, Grelli S, Matteucci C, Minutolo A, d'Ettorre G, Di Sora F, Montella F, Vullo V, Vella S, Favalli C, Macchi B, Mastino A.

J Med Virol. 2007 Feb;79(2):111-7.

PMID:
17177302
28.

Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):223-31. Epub 2006 Nov 13.

PMID:
17098349
29.

Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping.

Giuliani L, Coletti A, Syrjänen K, Favalli C, Ciotti M.

Anticancer Res. 2006 Sep-Oct;26(5B):3939-41.

30.

The p53 codon 72 arg/arg homozygous women in central Italy are at increased risk for HPV infections.

Ciotti M, Coletti A, Giuliani L, Cappiello G, Syrjanen K, Favalli C.

Anticancer Res. 2006 Sep-Oct;26(5B):3745-8.

31.

Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen S, Favalli C, Syrjänen K.

Diagn Cytopathol. 2006 Nov;34(11):739-48.

PMID:
17041957
32.

Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen SM, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Int J Gynecol Pathol. 2006 Oct;25(4):383-92.

PMID:
16990717
34.

Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen S, Favalli C, Syrjänen K; HPV-Pthogen ISS Study Group.

Diagn Cytopathol. 2006 Aug;34(8):555-63.

PMID:
16850495
35.

Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Eur J Gynaecol Oncol. 2006;27(3):215-23.

PMID:
16800245
36.

Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer.

Ciotti M, Giuliani L, Ambrogi V, Ronci C, Benedetto A, Mineo TC, Syrjänen K, Favalli C.

Oncol Rep. 2006 Jul;16(1):183-9.

PMID:
16786144
37.

Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Anticancer Res. 2006 Mar-Apr;26(2B):1543-56.

38.

Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Favalli C, Syrjänen K; HPV-Pathogen Istituto Superiore di Sanità Study Group.

J Clin Pathol. 2006 Oct;59(10):1044-51. Epub 2006 Mar 14.

39.

Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Acta Cytol. 2006 Jan-Feb;50(1):6-15.

PMID:
16514834
40.

Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjänen K; HPV-Pathogen ISS Study Group.

J Clin Pathol. 2006 Jan;59(1):40-7.

41.

Single or multiple HPV types in cervical cancer and associated metastases.

Ciotti M, Paba P, Bonifacio D, Di Bonito L, Benedetto A, Favalli C.

Oncol Rep. 2006 Jan;15(1):143-8.

PMID:
16328047
42.

Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Fontana C, Favaro M, Cicchetti O, Minelli S, Pistoia ES, Favalli C.

Jpn J Infect Dis. 2005 Oct;58(5):283-8.

43.

In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.

Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G.

Circ Res. 2005 Jul 22;97(2):152-8. Epub 2005 Jun 23.

PMID:
15976314
44.

Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.

Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, Benedetto A, Casolati EA, Favalli C, Paba P, Di Bonito P, Mariani L, Syrjänen S, Bonifacio D, Accardi L, Zanconati F, Syrjänen K; HPV-Pathogen ISS Study Group.

Am J Clin Pathol. 2005 Jul;124(1):113-21.

PMID:
15923164
45.
46.

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.

Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.

Eur J Gynaecol Oncol. 2004;25(6):689-98.

PMID:
15597844
47.

Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.

Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K; HPV-Pathogen ISS Study Group.

Am J Clin Pathol. 2004 Dec;122(6):902-11.

PMID:
15539382
48.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
49.

p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.

Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjänen K.

Int J Gynecol Pathol. 2004 Oct;23(4):354-65.

PMID:
15381905
50.

Polyoma virus BK and renal dysfunction in a transplanted population.

Splendiani G, Cipriani S, Condò S, Paba P, Ciotti M, Favalli C, Vega A, Dominijanni S, Casciani CU.

Transplant Proc. 2004 Apr;36(3):713-5.

PMID:
15110641

Supplemental Content

Loading ...
Support Center